Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
9.85
-1.36 (-12.13%)
At close: Nov 2, 2026, 4:00 PM EST
9.85
0.00 (0.00%)
After-hours: Nov 2, 2026, 7:00 PM EST
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $663.3 million as of November 2, 2026. It is the 11,588th most valuable company in the world and the 2,435th biggest in the United States. Its market cap has decreased by 7.87% in one year.
Market Cap
663.30M
Enterprise Value
765.25M
1-Year Change
-7.87%
Global Rank
Country Rank
#2,435 United States
Category
ChartMarket Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $663.30M, a decrease of -69.60%. That is a compound annual growth rate of -19.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 663.30M | 40.44% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helus Pharma | 774.07M |
| Sana Biotechnology | 769.36M |
| Annexon | 767.80M |
| Ardelyx | 755.04M |
| OmniAb | 742.94M |
| ArriVent BioPharma | 733.21M |
| Wave Life Sciences | 708.05M |
| Sagimet Biosciences | 703.41M |